Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló, Remedios
Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity. [electronic resource] - Thrombosis research 2006 - 487-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0049-3848
10.1016/j.thromres.2005.03.025 doi
Adult
Aged
Aged, 80 and over
Alleles
Breast Neoplasms--genetics
Enzyme-Linked Immunosorbent Assay
Female
Genotype
Humans
Middle Aged
Plasminogen Activator Inhibitor 1--genetics
Polymorphism, Genetic
Prognosis
Reverse Transcriptase Polymerase Chain Reaction
Severity of Illness Index
Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity. [electronic resource] - Thrombosis research 2006 - 487-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0049-3848
10.1016/j.thromres.2005.03.025 doi
Adult
Aged
Aged, 80 and over
Alleles
Breast Neoplasms--genetics
Enzyme-Linked Immunosorbent Assay
Female
Genotype
Humans
Middle Aged
Plasminogen Activator Inhibitor 1--genetics
Polymorphism, Genetic
Prognosis
Reverse Transcriptase Polymerase Chain Reaction
Severity of Illness Index